Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage
Hiroki Mizukami, … , Konrad Sandhoff, Richard L. Proia
Hiroki Mizukami, … , Konrad Sandhoff, Richard L. Proia
Published May 1, 2002
Citation Information: J Clin Invest. 2002;109(9):1215-1221. https://doi.org/10.1172/JCI14530.
View: Text | PDF
Article Genetics

Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage

  • Text
  • PDF
Abstract

Gaucher disease, the most common lysosomal storage disease, is caused by a deficiency of glucocerebrosidase resulting in the impairment of glucosylceramide degradation. The hallmark of the disease is the presence of the Gaucher cell, a macrophage containing much of the stored glucosylceramide found in tissues, which is believed to cause many of the clinical manifestations of the disease. We have developed adult mice carrying the Gaucher disease L444P point mutation in the glucocerebrosidase (Gba) gene and exhibiting a partial enzyme deficiency. The mutant mice demonstrate multisystem inflammation, including evidence of B cell hyperproliferation, an aspect of the disease found in some patients. However, the mutant mice do not accumulate large amounts of glucosylceramide or exhibit classic Gaucher cells in tissues.

Authors

Hiroki Mizukami, Yide Mi, Ryuichi Wada, Mari Kono, Tadashi Yamashita, Yujing Liu, Norbert Werth, Roger Sandhoff, Konrad Sandhoff, Richard L. Proia

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Total
Citations: 2 4 7 2 3 3 1 8 1 3 6 3 1 3 5 3 2 2 3 1 1 2 66
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (66)

Title and authors Publication Year
A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease
Furderer ML, Berhe B, Chen TC, Wincovitch S, Jiang X, Tayebi N, Sidransky E, Han TU
International journal of molecular sciences 2024
Functional Analysis of Human GBA1 Missense Mutations in Drosophila: Insights into Gaucher Disease Pathogenesis and Phenotypic Consequences
Kuppuramalingam A, Cabasso O, Horowitz M
Cells 2024
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions
Mahoney-Crane CL, Viswanathan M, Russell D, Curtiss RA, Freire J, Bobba SS, Coyle SD, Kandebo M, Yao L, Wan BL, Hatcher NG, Smith SM, Marcus JN, Volpicelli-Daley LA
Journal of Neuroscience 2023
Role of neuroinflammation in neurodegeneration development
Zhang W, Xiao D, Mao Q, Xia H
Signal Transduction and Targeted Therapy 2023
The Complexities of Diagnosis with Co-Existing Gaucher Disease and Hemato-Oncology—A Case Report and Review of the Literature
Sudul P, Piatkowska-Jakubas B, Pawlinski L, Galazka K, Sacha T, Kiec-Wilk B
Journal of Clinical Medicine 2023
Animal Models for the Study of Gaucher Disease
Cabasso O, Kuppuramalingam A, Lelieveld L, Van der Lienden M, Boot R, Aerts JM, Horowitz M
International journal of molecular sciences 2023
Inflammation and immune dysfunction in Parkinson disease.
Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V
Nature reviews. Immunology 2022
Gaucher disease - more than just a rare lipid storage disease.
Roh J, Subramanian S, Weinreb NJ, Kartha RV
Journal of Molecular Medicine 2022
Role of exosomes in the pathogenesis of inflammation in Parkinson's disease.
Li KL, Huang HY, Ren H, Yang XL
Neural Regeneration Research 2022
Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.
Arévalo NB, Lamaizon CM, Cavieres VA, Burgos PV, Álvarez AR, Yañez MJ, Zanlungo S
Frontiers in molecular neuroscience 2022
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
Rosenbloom BE, Cappellini MD, Weinreb NJ, Dragosky M, Revel\u2010Vilk S, Batista JL, Sekulic D, Mistry PK
American Journal of Hematology 2022
Immunogenetic Determinants of Parkinson's Disease Etiology.
Kung PJ, Elsayed I, Reyes-Pérez P, Bandres-Ciga S
Journal of Parkinson's disease 2022
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.
Kim J, Daadi EW, Oh T, Daadi ES, Daadi MM
Genes & development 2022
Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers With and Without Parkinson Disease
J Galper, M Balwani, S Fahn, C Waters, L Krohn, Z GanOr, N Dzamko, RN Alcalay
Movement disorders : official journal of the Movement Disorder Society 2021
C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages
JC Serfecz, A Saadin, CP Santiago, Y Zhang, SM Bentzen, SN Vogel, RA Feldman
International journal of molecular sciences 2021
Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease
V Schiffer, E Santiago-Mujika, S Flunkert, S Schmidt, M Farcher, T Loeffler, I Schilcher, M Posch, J Neddens, Y Sun, J Kehr, B Hutter-Paier, I Silman
PloS one 2020
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
P Dubot, L Astudillo, N Therville, F Sabourdy, J Stirnemann, T Levade, N Andrieu-Abadie
Cancers 2020
Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease
Y Buhidma, K Rukavina, KR Chaudhuri, S Duty
npj Parkinson's Disease 2020
The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases
N Nuzziello, M Liguori
Cells 2019
Role of Dysregulated Ion Channels in Sensory Neurons in Chronic Kidney Disease-Associated Pruritus
A Momose, M Yabe, S Chiba, K Kumakawa, Y Shiraiwa, H Mizukami
Medicines 2019
Recent Developments in LRRK2-Targeted Therapy for Parkinson’s Disease
Y Zhao, N Dzamko
Drugs 2019
Molecular regulations and therapeutic targets of Gaucher disease
Y Chen, N Sud, A Hettinghouse, C Liu
Cytokine & Growth Factor Reviews 2018
Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
M la Mata, D Cotán, M Oropesa-Ávila, M Villanueva-Paz, I Lavera, M Álvarez-Córdoba, R Luzón-Hidalgo, JM Suárez-Rivero, G Tiscornia, JA Sánchez-Alcázar
Orphanet Journal of Rare Diseases 2017
Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity
M Nagata, Y Izumi, E Ishikawa, R Kiyotake, R Doi, S Iwai, Z Omahdi, T Yamaji, T Miyamoto, T Bamba, S Yamasaki
Proceedings of the National Academy of Sciences 2017
Induced Pluripotent Stem Cell Modeling of Gaucher’s Disease: What Have We Learned?
D Santos, G Tiscornia
International journal of molecular sciences 2017
One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet
A Schmidt, T Woedtke, J Stenzel, T Lindner, S Polei, B Vollmar, S Bekeschus
International journal of molecular sciences 2017
Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study
KG Schmidt, MH san Juan, S Trautmann, L Berninger, A Schwiebs, FM Ottenlinger, D Thomas, F Zaucke, JM Pfeilschifter, HH Radeke
Frontiers in immunology 2017
Glucosylsphingosine Causes Hematological and Visceral Changes in Mice—Evidence for a Pathophysiological Role in Gaucher Disease
J Lukas, C Cozma, F Yang, G Kramp, A Meyer, AM Neßlauer, S Eichler, T Böttcher, M Witt, A Bräuer, P Kropp, A Rolfs
International journal of molecular sciences 2017
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
YV Taguchi, J Liu, J Ruan, J Pacheco, X Zhang, J Abbasi, J Keutzer, PK Mistry, SS Chandra
The Journal of neuroscience : the official journal of the Society for Neuroscience 2017
Gaucher disease: Progress and ongoing challenges
PK Mistry, G Lopez, R Schiffmann, NW Barton, NJ Weinreb, E Sidransky
Molecular Genetics and Metabolism 2017
The contribution of mutant GBA to the development of Parkinson disease in Drosophila
G Maor, O Cabasso, O Krivoruk, J Rodriguez, H Steller, D Segal, M Horowitz
Human Molecular Genetics 2016
Activation of p38 Mitogen-Activated Protein Kinase in Gaucher’s Disease
K Kitatani, M Wada, D Perry, T Usui, Y Sun, LM Obeid, N Yaegashi, GA Grabowski, YA Hannun, R Ahmad
PloS one 2015
Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages
E Aflaki, N Moaven, DK Borger, G Lopez, W Westbroek, JJ Chae, J Marugan, S Patnaik, E Maniwang, AN Gonzalez, E Sidransky
Aging Cell 2015
Clinical manifestations and management of Gaucher disease
S Linari
Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 2015
Glucocerebrosidase is shaking up the synucleinopathies
M Siebert, E Sidransky, W Westbroek
Brain 2014
Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease
PK Mistry, J Liu, L Sun, WL Chuang, T Yuen, R Yang, P Lu, K Zhang, J Li, J Keutzer, A Stachnik, A Mennone, JL Boyer, D Jain, RO Brady, MI New, M Zaidi
Proceedings of the National Academy of Sciences 2014
Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation
S Nair, CS Boddupalli, R Verma, J Liu, R Yang, GM Pastores, PK Mistry, MV Dhodapkar
Blood 2014
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation
I Fishbein, YM Kuo, BI Giasson, RL Nussbaum
Brain 2014
Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model
S Barnes, YH Xu, W Zhang, B Liou, KD Setchell, L Bao, GA Grabowski, Y Sun, A Dardis
PloS one 2014
Dysregulated Sphingolipid Metabolism in Endometriosis
YH Lee, CW Tan, A Venkatratnam, CS Tan, L Cui, SF Loh, L Griffith, SR Tannenbaum, JK Chan
The Journal of clinical endocrinology and metabolism 2014
The role of inflammation in sporadic and familial Parkinson’s disease
M Deleidi, T Gasser
Cellular and Molecular Life Sciences 2013
Animal models for metabolic, neuromuscular and ophthalmological rare diseases
G Vaquer, FR Dannerstedt, M Mavris, F Bignami, J Llinares-Garcia, K Westermark, B Sepodes
Nature Reviews Drug Discovery 2013
Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.
Mistry PK, Taddei T, vom Dahl S, Rosenbloom BE
Critical Reviews in Oncogenesis 2013
Gaucher disease gene GBA functions in immune regulation
J Liu, S Halene, M Yang, J Iqbal, R Yang, WZ Mehal, WL Chuang, D Jain, T Yuen, L Sun, M Zaidi, PK Mistry
Proceedings of the National Academy of Sciences 2012
Ceramides as Modulators of Cellular and Whole-body Metabolism
Benjamin T. Bikman, Scott Summers
Journal of Clinical Investigation 2011
Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
KJ Valenzano, R Khanna, AC Powe, R Boyd, G Lee, JJ Flanagan, ER Benjamin
ASSAY and Drug Development Technologies 2011
Animal models for Gaucher disease research
T Farfel-Becker, EB Vitner, AH Futerman
Disease models & mechanisms 2011
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
R Khanna, ER Benjamin, L Pellegrino, A Schilling, BA Rigat, R Soska, H Nafar, BE Ranes, J Feng, Y Lun, AC Powe, DJ Palling, BA Wustman, R Schiffmann, DJ Mahuran, DJ Lockhart, KJ Valenzano
FEBS Journal 2010
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
PK Mistry, J Liu, M Yang, T Nottoli, J McGrath, D Jain, K Zhang, J Keutzer, WL Chuang, WL Chuang, WZ Mehal, H Zhao, A Lin, S Mane, X Liu, YZ Peng, JH Li, M Agrawal, LL Zhu, HC Blair, LJ Robinson, J Iqbal, L Sun, M Zaidi
Proceedings of the National Academy of Sciences 2010
Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice
D Vruchte, A Jeans, FM Platt, DJ Sillence
Journal of Inherited Metabolic Disease 2010
Hyperferritinemia and iron overload in type 1 Gaucher disease
P Stein, H Yu, D Jain, PK Mistry
American Journal of Hematology 2010
Expanding spectrum of the association between Type 1 Gaucher disease and cancers: A series of patients with up to 3 sequential cancers of multiple types-Correlation with genotype and phenotype
SM Lo, P Stein, S Mullaly, M Bar, D Jain, GM Pastores, PK Mistry
American Journal of Hematology 2010
Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid
K Kitatani, K Sheldon, V Anelli, RW Jenkins, Y Sun, GA Grabowski, LM Obeid, YA Hannun
The Journal of biological chemistry 2009
Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI
A Tessitore, M Pirozzi, A Auricchio
PathoGenetics 2009
Type II Gaucher disease manifesting as haemophagocytic lymphohistiocytosis
LR Sharpe, P Ancliff, P Amrolia, KC Gilmour, A Vellodi
Journal of Inherited Metabolic Disease 2009
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
M Fost, TA Out, FA de Wilde, EP Tjin, ST Pals, MH van Oers, RG Boot, JF Aerts, M Maas, SV Dahl, CE Hollak
Annals of Hematology 2008
Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis
DE Sleat, M El-Banna, I Sohar, KH Kim, K Dobrenis, SU Walkley, P Lobel
Molecular Genetics and Metabolism 2008
Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency
C Settembre, I Annunziata, C Spampanato, D Zarcone, G Cobellis, E Nusco, E Zito, C Tacchetti, MP Cosma, A Ballabio
Proceedings of the National Academy of Sciences 2007
High incidence of autoantibodies in Fabry disease patients
P Martinez, M Aggio, P Rozenfeld
Journal of Inherited Metabolic Disease 2007
Upregulation of Proinflammatory Cytokines in the Fetal Brain of the Gaucher Mouse
YB Hong, EY Kim, SC Jung
Journal of Korean Medical Science 2006
Effective cell and gene therapy in a murine model of Gaucher disease
IB Enquist, E Nilsson, A Ooka, JE Månsson, K Olsson, M Ehinger, RO Brady, J Richter, S Karlsson
Proceedings of the National Academy of Sciences 2006
Glucosylceramide transfer from lysosomes—the missing link in molecular pathology of glucosylceramidase deficiency: A hypothesis based on existing data
M Elleder
Journal of Inherited Metabolic Disease 2006
Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology
R Sano, A Tessitore, A Ingrassia, A d'Azzo
Blood 2005
Possible role of autoantibody in the pathopysiology of GM2 gangliosidoses
Akira Yamaguchi, Kayoko Katsuyama, Kiyotaka Nagahama, Toshiyuki Takai, Ichiro Aoki and Shoji Yamanaka
Journal of Clinical Investigation 2004
Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease
YH Xu, B Quinn, D Witte, GA Grabowski
The American Journal of Pathology 2003
Future perspectives for glycolipid research in medicine
RA Dwek, TD Butters, FM Platt, TM Cox, TM Cox
Philosophical Transactions of The Royal Society B Biological Sciences 2003

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts